Achieve Life Sciences (ACHV)

• Market cap: $659M
• 1 day: 1.9%
• 5 days: 3.88%
• 1 month: -1.68%
• 3 months: 46.24%
• 6 months: 49.3%
• Year to date: 29.18%
• 1 year: 145.98%
• 5 years: -11.57%
• 10 years: -99.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Employees: 28